Final-New Material-Rachael Flashcards
(95 cards)
1
Q
Androgens
A
- androstenedione, DHEA, testrosterone, DHT
- Listed in order of potency
2
Q
Estrogens and Progestogens
A
- estrone, estriole, beta-estradiol (“estrogen”)
- Progesterone
3
Q
Hormone Signaling
A
- Non-polar hormones: secretion stimulated by stimulating enzymatic reactions
- Hormone bound to proteins in circulation
- Modification by enzymes in target cells
- Testosterone→dihydrotestosterone (DHT), more potent
- Enzyme: 5-alpha-reductase
- Androgens→estrogens
- Enzyme: aromatase
- Testosterone→dihydrotestosterone (DHT), more potent
- Enzymes can be drug targets
- Free hormones diffuses across plasma membrane of target cell
- Signaling via intracellular receptors that act as transcription factors
4
Q
Hormone Feedback Cycle
A

5
Q
Gametes Form by Meiosis
A
- Germ-cell: gametes and the gamete precursors
- 23 pairs of homologous chromosomes; 22 autosomes; 2 sex chromosomes
- Haploid cell has 23 single chromosomes
- In 1st division, the homologous chromosome pair up.
- Then they divide
- Crossing-over; recombination; variability
- Independent assortment; some of maternal and paternal end up dividing together
- In 2nd division, the chromatids divide up
6
Q
Nondisjunction lead to aneuploidy
A
- At first division: 2 of four have n-1, 2 of four have n+1
- At second division: 2 of four are normal, 1 n+1, 1 n-1
7
Q
Karyotype via amniocentesis or chorionic villus sampling and Cell Free DNA sampling
A
- Fetal cells: invasive: miscarriage or infection
- Placenta has fetal and maternal cells
- Branching is chorionic plate
- Protrudes into space created in endometrial spaceàmaternal blood flow
- Cell-free fetal DNA analysis:
- Small fragments of DNA enter the maternal circulation
- Early, non-invasive, blood draw
8
Q
Hormone regulation: pulsatile secretion of GnRH
A
- GnRH in the hypothalamus
- Anterior pituitary: gonadotropins
- Follicle stimulating hormone (FSH)
- Luteinizing hormone (LH)
- Negative feedback regulation by gonadal steroids
- *Some positive feedback occurs in female
- Gonadotropin (FSH, LH) secretion is stimulated by pulsatile GnRH, inhibited by continuous GnRH
9
Q
Review of Pituitary Hormones
A
- 3 hormone chain of command
- Magnocellular vs. parvocellular cell
- Magnocellular release to posterior pituitary
- Parvocellular release to median eminence, delivered directly to anterior pituitary (adenhypophesis)
10
Q
Continuous Treatment with GnRH
A
- Continuous treatment with GnRH agonist (eg. Leuprolide) used to turn off reproductive function
- Precocious puberty
- Androgen deprivation therapy for prostate cancer
- Decreased secretion of testosterone
- Used in treatment of prostate cancer, endometriosis, precocious puberty
- Cycle control for IVF
11
Q
Chronology of reproductive function
A
- GnRH secretion is high during sexual differentiation, low during childhood, and high after puberty
- Sexual differentiation is before birth
- Gonadal steroid secretion during lifetime in females and males
- Females spike up and down; drops in menopause (estrogen, progesterone)
- Early menopause: look for increase FSH, would occur because of removal of negative feedback inhibition
- Males spike and then slowly decrease with age
- Females spike up and down; drops in menopause (estrogen, progesterone)
12
Q
Leptin and GnRH
A
- Leptin is part of a negative feedback loop to control adiposity
- Need leptin to allow GnRH level to increase
- The obese mutant mouse fails to make leptin and suffers from hypogonadotropic hypogonadism
- Leptin is permissive for GnRH secretion
- In abscence, no GnRH, low FSH and LH, decreased gonadal function, infertility
- Doesn’t cause start of period: other factors turning on
- At certain level of leptin, factors more likely to turn on
- Leptin, environmental estrogens
- Hypoleptinemia in women
- Low body fat, low leptin secretion, amenorrhea
13
Q
Male Reproductive Anatomy
A
- Sperm develop in seminiferous tubules→epididymis→ductus deferens (vas deferens)→ejaculatory duct→urethra
- Semen: spermatozoa plus seminal fluid
- Seminal fluid made by accessory glands:
- Bulbourethral glands: make least amount of stuff neutralizes traces of urine
- Prostate gland (1)
- Seminal vesicle (2)
14
Q
Benign Prostatic Hypertrophy (BPH)
A
- Causes urinary symptoms
- Symptoms in 1/3 men over 50
15
Q
BPH Drugs
A
-
Alpha adrenergic antagonists: Tamsulosin (Flomax)
- Relax smooth muscle in urethra
- Really specific for alpha receptors in the urethra and less likely to bind other subtypes-Not have to worry about blood pressure effects as much
-
5-alpha reductase inhibitors
- Dutasteride, finasteride
- Prostate heavily influenced by DHT
- Prevent testosterone to DHT
16
Q
Prostate Cancer
A
- Tends to be very slow growing
- Incidence and mortality of prostate cancer: effect of increased screening with PSA test
- Not specific to cancer because BPH also tests positive
- Lots of cancer diagnosis, over diagnosis
- Mortality didn’t actually go down
- Early screening has no benefit on cancer mortality rate
- Best option in most cases is to leave it alone
- Treatment increases morbidity and side effects
- Urinary, defecation, etc. can be messed up
17
Q
Spermatogenesis
A
- Differentiation from spermatid to spermatozoon
- Head of sperm:
- Nucleus
- Vesicle called the acrosome
- Contains digestive enzymes
- Important in fertilization
- Sperm made: 100 Million per day, 1000 per second
- Need 15 million sperm per mL for fertility
- Leydig cells: make testosterone

18
Q
Migration of Developing Sperm in Seminiferous Tubule (Figure)
A

19
Q
Sertoli Cells
A
- Like epithelium that wrap around and hang onto developing germ cells
- Create blood testis barrier
- Between inside of seminiferous tubule and blood
- Tight junx between sertoli cells
- Basal: spermatagonia
- Central: meiosis and mature gametes
- Isolates from immune system (central compartment)
- Nourishing/paracrine signaling required for spermtagonenisis
- Receptors for FSH and testosterone
- Produce androgen binding protein
- Endocrine cells that produce:
- Inhibin: negative feedback
- Mulllerian inhibiting substance (MIS): involved in sexual differentiation
20
Q
Sertoli Cell Functions: Summary
A
- Blood testis barrier
- Support gamete development
- Responds to FSH, testosterone
- Synthesize androgen binding protein
- Secrete hormones:
- Inhibin
- Mullerian Inhibiting Substance
21
Q
Male Hormonal Regulation
A
- Leydig cells bind to LH
- Sertoli cells bind to FSH
- Negative feedback of tropin
- Not on and off: rather fine tuning
- Muscle mass, bone growth, protein synthesis, secondary sexual structure, sex drive

22
Q
Physiology of erection
A
- 1 corpus sponginosum and 2 corpus cavernosa
- Erectile tissues that are vascular spaces that can fill up with blood and become engorged
- Relaxation of arterials and smooth muscles allows blood to flow in
- Maintenance helped because filling up compresses the veins
- neural inputs to arterial smooth muscle of the penis:
- NANC (nonadrenergic, noncholinergic) neurons:
- Releases nitric oxide as neurotransmitter
- Nitrergic neurons
- Sympathetic neurons:
- Release norepinephrine

23
Q
Erectile Dysfunction Drugs
A
- Phosphodiesterase inhibitors
- Oral drugs to treat ED
- NO stimulates guanylate cyclase
- Make cGMP
- Lead to decrease in Ca and relaxation
- PDE inactivates pathway by cleaving cGMP
- Sildenafil, vardenafil, tadalafil, avanafil

24
Q
Ejaculation
A
- Semen from urethra
- Smooth muscle contraction around the ducts
- Depends on the sympathetic input to smooth muscle
- Vas deferens + Ejaculatory Duct
- Glands
- Internal urethral sphincter
- Release of semen from penis
- Contraction of smooth muscle in urethra
- Contraction of skeletal muscles in pelvic floor
25
Sexually Indifferent Stage
* During embryonic development
* Adjacent to each primitive gonad
* Wolffian (mesonephric) ducts are more medial
* Müllerian (paramesonephric) ducts are more lateral, but then fuse in the midline more caudally

26
Sexual Determination: Male
* Sexual determination: depends upon the sex chromosomes, X and Y
* SRY gene on Y chromosome
* activates a gene network that directs the gonads to develop as testes
* No SRY, goes to ovaries
* Testes generate regulatory molecules
* MIS=Mullerian Inhibiting Substance
* peptide hormone

27
Sexual Determination: Female
* Female in absence of SRY gene

28
MIS Information
* produced in the ovary (after it differentiates) by granulosa cells
* expressed mainly by small growing follicles
* level of MIS is thus a good indicator of the size of the ovarian reserve
* Used in IVF to predict how the woman will respond to controlled ovarian stimulation
29
Androgen Insensitivity Syndrome
* Mutation in androgen receptor
* "complete androgen insensitivity"
* Testes develop
* Externally as a female
* development of the male external genitalia depends upon androgen
* Breasts develop because testosterone converted to estrogen
* Recognized via amenorrhea
* Uterus never developed because MIS caused regression
* No armpit or pubic hair because these depend on androgen signaling

30
Treatment for Androgen Insensitivity Syndrome
* Removal of abdominal testes
* gonadectomy
* Increased risk for testicular cancer
* Cryptorchidism (failure of testes to descend)
* Low androgen levels
* Wait until early adulthood and then gonadectomy so that naturally goes through puberty
* After gonadectomy, kept on hormone therapy
31
Mutation in 5-alpha-reductase
* Penis and prostate development depends upon dihydrotestosterone (DHT)
* Mutation in 5-alpha-reductase type 2
* Born externally female
* Hypospadias
* Urethra not in phallus but in the perineum
* At pubery the large levles of testosterone stimulate the development of male structures
* Male secondary structures develop
* Initially raised as girls and then develop male gender identity
*

32
Other Ovarin Development Signals
* Occurs in absence of SRY gene
* But doesn't occur by default
* Several genes (RSPO1, WNT4, FOXL2) have been shown to be necessary to initiate ovarian development
* actively repress gene network for testes development
33
Comparing Male vs. Female:
* Spermatagonia
* Spermatocyte divisions
* # of germ cells

34
Female Oogensis Flowchart

35
Oocytes develop into follicles
* Prior to birth, oogonia stop proliferating
* At birth, germ cells in ovaries are primary oocytes
* Initiated meiosis but are then in meiotic arrest
* Oocyte+support cells=follicle
* Not developing=primordial follicles
* oocyte in meiotic arrest surrounded by a single layer of follicle cells
* Once starts to develop:
* Oocyte enlarges
* Follicle cells differentiate to granulosa cells, proliferate
* Zona pellucida: glycoproteins
* Spindle shaped theca cells
* Fluid-filled antrum
36
Follicle Development: Independent Development
* Local signals in ovary cause follicles to develop into early antral stage
* Independent of gonadotropins
* Before puberty and any time in monthly cycle
37
Follicle Development: Growth Phase
* Follicles that have undergone initial development
* Further stimulated by rising gonadotropins (FSH) and (LH)
* If intial development not later hormonally supported, undergoes **atresia**
* 99.9%
* Happens all throughout childhood
* Fewer ovulations, less ovarian cancer risk
* Growing, antral follicles
38
Follicle Development: Dominant Follicle
* Dominant follicle selected by day 7
* Day 7-14 matures
* Egg and small cluster of granulosa cells detaches from wall and follicle floats free within antrum
* Ovulation on day 14
* **Follicular phase**
39
Follicle Development: Post Ovulation
* Remaining follicle cells into corpus luteum
* Granulosa cells increase, BM broken down, invaded by blood vessels
* Corpus luteum secretes progesterone and estrogen
* Degenerates day 25 and 28 when LH levels decline
* Fertilized embryo will make chorionic gonadotropin, LH analog that allows corpus luteum to persist during first trimester
* **Luteal Phase**
40
Hormonal Regulation: Early Follicular Phase
* Growth stimulated by Gn
* Decreasing estrogen and progesterone from end of cycle release the negative feedback on the anterior pituitary
* FSH=granulosa cells
* LH=theca cells
* Start secreting estrogen
* Granulosa: enzyme aromatase (makes beta estradiol)
* Theca: androgen precurosor

41
Hormonal Regulation: Selection of Dominant Follicle and Late Follicular Phase
* Follicle enlarges and increases estrogen secretion
* Causes negative feedback inhibition
* Gn levels decline (esp. FSH)
* Granulosa secrete inhibin to prevent FSH
* Selection because negative feedback limits FSH
* Granulosa cells develop LH receptors in late follicular phase and start reponding to LH

42
Hormonal Regulation: LH surge and Ovulation
* Estrogen from follicle cross threshold and estrogen causes postive feedback
* Causes rapid rise in LH ("surge")
* Causes ovulation
* Just prior to ovulation, LH causes a blip of progesterone secretion (needed for ovulation)
* First division of meisosis occurs just prior to ovulation

43
Hormonal Regulation: Luteal Phase
* LH stimulates formation of corpus luteum
* Secretes estrogen and progesterone
* Negative feedback on Gn
* Prevents further follicle development and ovulation
* LH levels fall below a threshold and corpus luteum regresses
* Release hypothalamus and pituitary from negative feedback inhibition
* FSH and LH steadliy increase to start new cycle

44
Complete Diagram of Female Cycle

45
Coordination of Uterine Events
* Endometrium into functional layer under estrogen and progesterone control
* Basal layer that regenerates functional layer after menustration
* Middle and Late Follicular Phase:
* High estrogen cause proliferation (**proliferative phase**); cervix secrete thin watery mucus
* Inductiov of progesterone receptors
* Luteal Phase
* Progestrone prevent further proliferation
* Blood vessel growth
* **Secretory Phase**
* Cervix secrete thick mucus
* Inhibit contractions
* Menustration
* Drop in progestrone and estrogen
* Vasocontriction causes ischemia
* Later vasodialation to causes bleeding and contraction of myometrium
46
Menorrhagiae
Dysmenorrhea
* Menorrhagiae: excessive uterine bleeding
* Dysmenorrhea: painful menustration
47
Leiomyoma
* "Fibroids"
* Benign growths in myometrium
* Abnormal entometrial growth over fibroids leads to excessive bleeding
* More common in older women, have hystorectomy
48
Unopposed Estrogen
* Occurs in PCOS
* PCOS: annovulation: no switch to luetal or secretory phase
* Lots of estrogen and not a lot of progesterone
* Endometrium keeps proliferating
* Miss a bunch of periods and then have a really bad period
* Increased risk for endometrial cancer
* Treated with hormonal contraceptives
49
Hyperprolactinemia: Prolactin regulation
* Stimulates milk production in the breast/growth
* Estrogen and progesterone prevent lactation
* Suckling stimulates mechanoreceptors
* Magnocellular Cell:
* Release oxytocin from posterior pituitary
* Milk ejections from myoepithelial cells
* Parvocellular cell that release dopamine at the median eminence
* Dopamine travel to the anterior pituitary via hypophyseal portal vessels and inhibit prolactin secretion
* Suckling inhibits dopamine release

50
Hyperprolactinemia: Causes and Treatments
* Pituitary tumor (prolactinoma) that secretes prolactin
* Cause infertility because prolactin inhibits GnRH secretion
* Low GnRH, low FSH and LH
* Hypogonadotropic hypogonadism
* anovulation
* amenorrhea and galactorrhea
* osteoprosis
* Dopamine antagonists can cause hyperprolactima
* Gonadal hormone treatment
* First line treatment is dopamine agonist
* bromocriptine and cabergoline

51
PCOS: Description
* Most common cause of anovulatory infertility
* Chronic ovulation problems with hyperandrogenism
* Amenorrhea or oligomenorrhea
* Hirsutism, acne, hair loss on scalp
* Ovaries enlarged with multiple immature follicels
* Hyperplasia of theca cells
* Fewer granulosa cells
* No domininant follicle chosen and on LH surge
* Often insulin resistant: hyperinsulinemia , greater T2DM risk
* Ultrasound show "necklace of black pearls"
52
Endocrine disturbances in PCOS
* Normal follicle development when estrogen and progesterone levels drop due to degeneration of corpus luteum
* Granulosa respond to FSH and Theca to LH
* In PCOS, LH secretion is elevated (FSH the same or decreased)
* Theca cells and androgens produced but there is not enough FSH to stimulate granulosa cells
* Failure of follicle development to progress
* Androgen converted to estrogens in adipose tissue
* Abnormal feedback regulation
* LH continues to be high compared to FSH
* Hyperinsulinemia contributes because insulin stimulates androgen production

53
Treatment for PCOS: Hormonal Contraceptives
* Decrease hyperandrogenism and negative effects on uterus
* Estrogen and progestrone restore normal LH levels
* PCOS causes there to be unopposed estrogen because never progress to luteal phase that has progesterone
* Continued proliferation leading to menorrhagia
* Increases risk for endometrial cancer
54
Treatment for PCOS: Clomiphene
* SERM
* In hypothalmus and anterior pituirtary, acts as estrogen antagonist
* prevents negative feedback effect of estrogen, allows FSH secretion to increase so that follicle development can be stimulated
* Taken at a certain time in cycle to snap out of bad habits
* Potential for mulitple ovulations
* Alters uterine environment making it harder to concieve
* Usually 1st line in those wanting to concieve
55
Treatment for PCOS: Aromatase inhibitors
* Letrozole and anastrozole efficicay in ovulation induction
* Prevent androgens from converting to estrogens
* Limit estrogen negative feedback on GnRH
* Shorter half-life allowing normal estrogen secretion later in cycle
* Less risk for multiple ovulations
* More estrogen stimulation of endometrial development during proliferative phase
56
Tratement for PCOS: insulin sensatizers
* Metformin
* Safe and effective in lowering androgen levels
57
Treatment for PCOS: Gonadotropins
* Exogenous FSH
* Menotropin
* mixture of gonadotropins from menopausal urine
* Urofollitropin
* purified FSH from urine
* Follitropin
* Recombinant FSH
* FSH may lead to multiple ovulations
* Ovarian hyperstimulation syndrome, increased vascular permeability (edema, nausea, abdominal pain)
* Severe: clotting abnormalities, renal failure, respiratory distress
58
Treatment for PCOS: Ovarian Surgery
* Induce damage to ovarian tissue
* Breaks the cycle of androgen production and abnormal negative feedback
* No risks of hyperstimulation or multiple pregnancy
59
PCOS Treatments for women who do not want to concieve
* Hormonal Contraceptives
* Weight Loss
* Metformin
60
PCOS treatments for women who **do** want to concieve
* Clomiphene
* Weight Loss
* Aromatase Inhibitors
* Metformin
* FSH
* Surgery
61
Definition of Conception
* Implantation of fertilized embryo
* Measure by increase in chorionic gonadotropin
* Measure ovulation by LH surge
62
Hormonal Contraceptive: MOA
* Suppress the secretion of gonadotropins (FSH and LH) thorugh negative feedback inhibition
* Inhibit during luteal phase
* Suppress ovulation
* Prevent rise in FSH needed for initiation of follicle development and selection of dominant follicle
* Prevents LH surge needed to trigger ovulation
* In follicular phase, estrogen makes thin water mucus that sperm can traverse
* In luteal phase, progesterone makes thick mucus. Progesterone in HC does this
* Reduce endometrial growth and interfere with implantation
* Side effect: mid-cycle bleeding from abnormal endometrial proliferation

63
Combination Contraceptives
* Estrogen and progestin
* Placebo causes withdrawl bleed
* Sign not prego, but not essential
* Continuous for women who suffer menorrhagiae or dysmenorrhea
64
Progesterone Only Contraceptives
* Low Dose Pills
* Not as reliable at preventing ovulation but work by thickening cervical mucus
* Must be taken at the same time everyday
* Good for lactating mothers
* Long-Acting Methods
* Depo-Provera
* Injected every 3 months
* Inhibition of estrogen may cause loss in bone density
65
Emergency Contraception

* Block or delay ovulation since sperm can be in reproductive tract for days
* Plan B (levonorgesterol in higher dose)
* Negative feedback inhibitior of GnRH
* Only works if taken **before** LH surge
* Use within 12 hrs, but can be effective for 5 days
* Ella (ulipristal acetate)
* selective progesterone receptor modulator
* Blocks progesterone action in follicle
* Small increase in progesterone caused by LH surge
* Delay ovulation even if begining of LH surge has already occured
* Not effective if taken after the peak of LH surge
* May affect endometrium, but very low doses so maybe not

66
Hormonal Contraceptives: Risks
* Cardiovascular Risk
* Rare in young women and pregnancy increases these risks even greater
* Promote thrombosis (VTE); pulmonary embolism, MI or stroke
* Clotting due to estrogen
* Newer progestin (drospirenone, desogestrel) have higher risk than older (levonorgestrel)
* Breast Cancer
* Tumors stimulated by estrogen
* Estrogen and Progesteronen promote breast growth
* No increase in breast cancer (but study done in older women)
*
67
Hormonal Contraceptives: Benefits
* Menstural Symptoms:
* Menorrhagia, dysmenorrhea, PCOS
* Endometrial Cancer:
* Decreased endometrial proliferation
* Lowest risk in those of HC for longest
* Ovarian Cancer:
* Lowest risk in those on HC for longest
* Androgen Secretion
* Treat hyperandrogenism because decrease gonadotropin androgen secretion
* Reduce severity of acne
68
Mifepristone
* Progesterone antagonist
* Terminate pregnancy in first 7 weeks
* Need progesterone to keep gestation
* Progesterone maintains endometrium and quiet myometrium
* Mifepristone and then prostaglandins
* prostaglandins induce myometrial contractions
* Mifepristone induces shedding of endometrium
* Ella progesterone antagonist is used at a much lower dose
69
Acrosome Reaction
* Sperm matures as goes through female reproductive tract
* Acrosome: large vesicle in head of sperm; contains digestive enzymes
* Sperm bind to zona pellucida; acrosome reaction is undergone
* Release of digest enzyme; allows sperm to burrow through zona pellucida
* Many sperm undergo acrosome reaction, but only one “wins”
* Once sperm membrane fuses with egg membrane; triggers a reaction in the ovum (cortical reaction)
70
Cortical Reaction
* Exocytosis of vesicles
* Change the zona pellucida; zona hardening
* Other sperms that are bound fall off and prevents other sperms from fertilizing the egg
* Zona pellucida stay with the fertilized egg (conceptus)
* Give rise to embryo and extra embryonic tissue
* Sperm-egg fusion stimulated the second division of meiosis
* Male and Female pronucleus fuse and then divide to make zygote (other female nucleus is the polar body)
71
First Cell Divisions in Pregnancy
* First cell divisions through fallopian tube occur without any growth; cleavage
* 70-100 cells
* Zona pellucida prevents it from implanting where it shouldn’t
* Blastocyst
72
Implantation-stage conceptus: blastocyst
* Once reaches the uterus, there is zona hatching
* Two kinds of cell in blastocyst
* Trophoblast: Outer layer that forms extra embryonic tissue (chorion)
* Inner Cell Mass: Cell concentrated on one side; forms embryo
73
Trophoblast
* Trophoblast is sticky and adheres to endometrium
* Promotes proliferation
* Divides into two groups
* Syncytial trophoblast: cell membrane break down, so many nuclei in one membrane
* Invasive into endometrium
* Proteolytic enzymes
* Makes chorionic gonadotropin
* Makes lacuna
* Cellular trophoblast: normal cells
* Forms chorionic villi

74
Implantation
* Occurs 6 to 7 days after fertilization
* syncytial trophoblast
* invasisive and proteolytic enzymes
* embyro nourished by digestion of endometrium
* Digestion of endometrial tissue creates lacunae
* produce chorionic gonadotropin
* Pregnancy test
* LH analog, maintains corpus luteum
* Cellular trophobasts create branched structures, known as chorionic villi
* developing embryo forms a disc that pulls away from the proliferating trophoblast to create a new space
* amniotic cavity

75
The Placenta
* from the trophoblast and the endometrium
* during pregnancy the endometrium is known as the **decidua**
* Placenta 5 wks after implantation
* fetal part of the placenta, or chorion, is made up of the chorionic villi
* branched
* blood vessels just under trophoblast layer
* villi protrude into large spaces (lacunae) in the decidua
* maternal blood into lacunae to wash over villi
* exchange of nutrients, wastes, and blood gases
* Source of estrogen and progesterone after 8 weeks of pregnancy
76
Development of the Amnion
* Development of the amnion
* Fluid filled
* Chorion develops on one side and then fuses with the amnion
* Chorion will be on one side of the uterus
77
Estrogen and Progesterone in Pregnancy: Immplantation
* Gonadosteroid make the uterus prime for immplantation
* Estrogen in follicular phase proliferates endometrium
* Progesterone in luteal phase stimulates secretion and promotes blood vessel growth
* Estrogen and Progesterone by corpus luteum
* Early in pregnangy CL stimualted by HCG
* By 4 weeks there are detectable levels of HCG
78
Estrogen and Progesterone in Pregnancy: Gestation
* Progesterone: smooth muscle relaxation in the myometrium, developmental changes in endometrium for decidua formation
* Progesterone supplementation in women who have a history of preterm labor
79
Graph of Hormonal Changes in Pregnancy

80
Estrogen and Progesterone in Pregnancy: Preparation for Lactation
* Progesterone stimulates growth of milk-producing cells in the glands
* Estrogen stimulates growth of duct cells
* Estrogen stimulated prolactin
81
Partruition
* Delivery of infant and placenta
* Estrogen stimulates proliferation in the myometrium
* synthesis of gap junctions between myometrial smooth muscle cells
* Coordinated contraction
* synthesis of enzymes involved in prostaglandin synthesis
* Prostaglandin cervical ripening
* Soft, flexible and dialated
* Prostaglandins stimualte myometrial contractions
* oxytocin is the strongest stimulator of uterine contractions
* estrogen increases responsiveness to oxytocin by increasing expression of oxytocin receptors
82
Partruition: Hormonal Loop
* Head pushes head against the cervix
* Stretch receptors in the cervix
* Feed onto the hypothalamus
* Activate neurosecretory cells to release more oxytocin
* Positive feeback stimulation to make sure that the baby is born “all the way”

83
Strucutre of the Breast
* Milk is produced by secretory structures known as alveoli
* Alveoli are arranged in clusters called lobules
* The lobules are connected to outlets at the nipple by ducts
* The alveoli are surrounded by special contractile cells known as myoepithelial cells.
84
congenital adrenal hyperplasia
* Problems with sexual differentiation of XX infants
* when excess androgens are produced during development
* can be due to an adrenal tumor in the mother
* most often in the disorder known as congenital adrenal hyperplasia
* defects in the enzymatic pathways that produce cortisol
* Low cortisol cannot exert negative feedback regulation on the secretion of the pituitary hormone ACTH, which stimulates hormone production by the adrenal gland
* adrenal glands produce large amounts of androgens, which have the effect of masculinizing XX females
* precocious sexual development in males
85
Cryptorchidism
* Failure of both testes to descend into the scrotum by birth
* Surgical correction of cryptorchidism is done ideally before 2 years of age and is known as orchiopexy
* Cryptorchidism increases risk for testicular cancer and orchiopexy reduces this risk
86
Testicular cancer
* most common malignancy in young men
* vast majority of testicular cancers (95%) are germ cell tumors
* these tumors arise when there is disrupted growth and development of germ cell precursors
* the cure rate approaches 80%
* removal of the tumor, followed by radiation, or chemotherapy
* chemotherapy drug **cisplatin** has proved to be very effective in the treatment of testicular cancer
87
Benign Prostatic Hyperplasia
* non-cancerous growth of the prostate gland
* pelvic pain and difficulty in urination
* prostate is more responsive to DHT, one therapeutic approach uses 5-a-reductase inhibitors, such as dutasteride and finasteride
* Another medical approach is to use a–blockers (an example is tamsulosin), which relax smooth muscle in the prostate and urethra to ease urinary symptoms
* Surgical resection of the enlarged prostate can also be done using an instrument inserted in the urethra.
88
Prostate Cancer
* most frequently diagnosed cancer among men in the United States
* Detection of prostate tumors was traditionally done by digital rectal examination
* Prostate-specific antigen (PSA) is a protein produced by the prostate, and its levels rise in the blood when the prostate enlarges, as it would if a tumor was present
* high rates of false positives and false negatives
* Treat with hormonal therapy
* Radiation
* prostatectomy
89
Breast Cancer
* mammography also causes overdiagnosis, that is, the identification of tumors that may not be otherwise clinically significant in a woman’s lifetime
* non-invasive (confined to breast ducts or lobules) or invasive (spread to surrounding connective tissue)
* Another term for non-invasive breast cancer is carcinoma in situ
* To determine whether breast cancer has metastasized, the axillary lymph nodes (lymph nodes of the armpit) are dissected and examined.
* over-expresses hormone receptors (either for estrogen or progesterone) or the growth factor receptor HER2
* treat it with drugs that interfere with estrogen, such as tamoxifen (which is a selective estrogen receptor modulator; SERM) or letrozole (an aromatase inhibitor that prevents estrogen synthesis). Tumors that are positive for HER2 are treated with trastuzumab (tradename: Herceptin), an antibody-based drug that binds to the receptor and prevents cell growth.
90
Breast Cancer Surgery
* mastectomy (removal of the breast) or lumpectomy, in which the tumor and surrounding tissue are removed
* lumpectomy after radiation
* Adjuvant therapy refers to any of the various systemic therapies: chemotherapy, hormone therapy, or trastuzumab.
91
Breast Cancer and HRT
* hormone replacement therapy increased the risk of heart disease and breast cancer
92
PID
* acute infection of the upper reproductive tract in women, namely endometritis
* salpingitis (infection of the fallopian tubes)
* oophoritis (infection of the ovaries)
* Usually by the clap
* pelvic pain, tenderness upon palpation, and (sometimes, but not always) vaginal discharge
* Can lead to infertility and tubal dysfunction
* Treat with antibiotics
93
Endometriosis
* endometrial tissue is found in ectopic locations, usually in the pelvic cavity
* pelvic pain, tissue damage, and lowered fertility
* retrograde menstruation (i.e. menstruation through the fallopian tube instead of the cervix) allows ectopic endometrial tissue to implant in the pelvic cavity
* persist there due to an insufficient immune response
* treated surgically, or with drugs that decrease estrogen levels such as oral contraceptives or the GnRH agonist leuprolide
94
Dysmenorrhea
* painful menstruation
* High prostaglandin levels
* sensitize pain fibers in the uterus
* treated effectively with NSAIDs (non-steroidal anti-inflammatory drugs)
* oral contraceptives
* Progesterone opposes prostaglandin function
* less endometrium overal lowers prostaglandin secretion as well
95
Menopause
* end of ovarian follicle production, there is also a marked drop in production of estrogen
* decrease in the size of the breasts and uterus
* bone density and cardiovascular system
* lack of estrogen leading to hot flash
* HRT for vaginal dryness and hot flash and osteoporosis
* Treatment of estrogen loss:
* selective estrogen receptor modulators (SERMs), such as raloxifen
* act as estrogen antagonists in some tissues, while acting as estrogen agonists in other tissues
* Raloxifene may now also be prescribed to prevent breast cancer in post-menopausal women at high risk for invasive breast cancer.